ARCUTIS BIOTHERAPEUTICS INC (ARQT) Institutional Ownership Changes & 13F Activity
ARCUTIS BIOTHERAPEUTICS INC (ARQT). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Suvretta Capital Management, Llc, Polar Capital Holdings Plc, Gilder Gagnon Howe & Co Llc, D. E. Shaw & Co., Inc., and Driehaus Capital Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Op Asset Management Ltd | Sell | -10 | -0.1% | 14,866 | $431.71K | Q4 2025 | Sep 28, 2026 |
| Advisors Asset Management, Inc. | Sell | -47,232 | -100.0% | 0 | $0.00 | Q4 2025 | Aug 26, 2026 |
| Ensign Peak Advisors, Inc | Sell | -90,665 | -4.5% | 1,902,390 | $55.25M | Q4 2025 | Aug 18, 2026 |
| Algert Global Llc | Sell | -143,132 | -62.4% | 86,260 | $2.50M | Q4 2025 | Aug 11, 2026 |
| Independent Financial Group, Llc | Buy | +16,458 | — | 16,458 | $477.94K | Q4 2025 | May 15, 2026 |
| Sunbelt Securities, Inc. | Buy | +22 | — | 22 | $639.00 | Q4 2025 | Feb 20, 2026 |
| Mcguire Capital Advisors Inc | Buy | +510 | — | 510 | $14.81K | Q4 2025 | Feb 19, 2026 |
| Raymond James Financial Inc | Buy | +144,949 | — | 144,949 | $4.21M | Q4 2025 | Feb 18, 2026 |
| Mackenzie Financial Corp | Buy | +49,025 | — | 49,025 | $1.37M | Q4 2025 | Feb 18, 2026 |
| Mercer Global Advisors Inc | Buy | +8,785 | — | 8,785 | $255.12K | Q4 2025 | Feb 18, 2026 |
| Newedge Advisors, Llc | Buy | +1,545 | — | 1,545 | $44.87K | Q4 2025 | Feb 18, 2026 |
| Suvretta Capital Management, Llc | Buy | +11,964,000 | — | 11,964,000 | $347.43M | Q4 2025 | Feb 17, 2026 |
| Polar Capital Holdings Plc | Buy | +5,556,169 | — | 5,556,169 | $161.35M | Q4 2025 | Feb 17, 2026 |
| Gilder Gagnon Howe & Co Llc | Buy | +4,453,856 | — | 4,453,856 | $129.34M | Q4 2025 | Feb 17, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +2,683,087 | — | 2,683,087 | $77.92M | Q4 2025 | Feb 17, 2026 |
| Driehaus Capital Management Llc | Buy | +2,562,445 | — | 2,562,445 | $74.41M | Q4 2025 | Feb 17, 2026 |
| Janus Henderson Group Plc | Buy | +1,830,061 | — | 1,830,061 | $53.15M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +1,673,454 | — | 1,673,454 | $48.60M | Q4 2025 | Feb 17, 2026 |
| Price T Rowe Associates Inc | Buy | +1,166,348 | — | 1,166,348 | $33.87M | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +955,235 | — | 955,235 | $27.74M | Q4 2025 | Feb 17, 2026 |
| Voloridge Investment Management, Llc | Buy | +914,020 | — | 914,020 | $26.54M | Q4 2025 | Feb 17, 2026 |
| Oberweis Asset Management Inc/ | Buy | +808,400 | — | 808,400 | $23.48M | Q4 2025 | Feb 17, 2026 |
| Qube Research & Technologies Ltd | Buy | +661,415 | — | 661,415 | $19.21M | Q4 2025 | Feb 17, 2026 |
| Nearwater Capital Markets, Ltd | Buy | +615,000 | — | 615,000 | $17.86M | Q4 2025 | Feb 17, 2026 |
| Rockefeller Capital Management L.P. | Buy | +551,958 | — | 551,958 | $1.50M | Q4 2025 | Feb 17, 2026 |
| Mpm Bioimpact Llc | Buy | +531,200 | — | 531,200 | $15.43M | Q4 2025 | Feb 17, 2026 |
| Bamco Inc | Buy | +504,700 | — | 504,700 | $14.66M | Q4 2025 | Feb 17, 2026 |
| Capitolis Liquid Global Markets Llc | Buy | +500,000 | — | 500,000 | $14.52M | Q4 2025 | Feb 17, 2026 |
| Cormorant Asset Management, Lp | Buy | +500,000 | — | 500,000 | $14.52M | Q4 2025 | Feb 17, 2026 |
| Aqr Capital Management Llc | Buy | +499,418 | — | 499,418 | $14.50M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about ARQT activity
Which institutional owners are buying ARQT?
Institutional owners buying ARQT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ARQT activity?
"Buy" means an investor increased their reported position in ARQT compared to the prior reporting period. This reflects growing exposure to ARCUTIS BIOTHERAPEUTICS INC (ARQT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ARQT increasing?
Institutional interest in ARQT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ARQT Institutional Insights
- ARQT Overview
- ARQT 13F Institutional Holders
- ARQT Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ARQT Insider Trading & SEC Form 4 Activity
- ARQT Articles
- Top Institutional Investor Stock Rankings